Perrigo Announces the Launch of Guaifenesin Extended-Release 600mg Tablets
Perrigo Company (Nasdaq: PRGO) announced that it has initiated shipments of its Guaifenesin Extended-Release Tablets, 600mg (a generic version of Mucinex® 600mg tablets) product. This launch consists of product packaged in bottles to a number of customers. The company expects to initiate its full-scale over-the-counter (OTC) launch of product in blister packaging to its retail and wholesale customers in store brand or own label before the end of its current fiscal year.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.